We are live on ! Find out more
BLC

Brown, Lisle/Cummings Portfolio holdings

AUM $400M
1-Year Est. Return 18.79%
This Fund
S&P 500
This Quarter Est. Return
+1.94%
1 Year Est. Return
+18.79%
3 Year Est. Return
+61.76%
5 Year Est. Return
10 Year Est. Return
AUM
$307M
AUM Growth
+$12.5M
Cap. Flow
+$10M
Cap. Flow %
3.27%
Top 10 Hldgs %
28.69%
Holding
624
New
65
Increased
120
Reduced
105
Closed
11

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$1.18M
2
CHD icon
Church & Dwight Co
CHD
+$741K
3
VRT icon
Vertiv
VRT
+$437K
4
HON icon
Honeywell
HON
+$430K
5
AMZN icon
Amazon
AMZN
+$401K

Top Sells

Rank Stock Value
1
WPC icon
W.P. Carey
WPC
+$312K
2
MFC icon
Manulife Financial
MFC
+$278K
3
PYPL icon
PayPal
PYPL
+$163K
4
INTC icon
Intel
INTC
+$143K
5
NVO
Novo Nordisk
NVO
+$142K

Sector Composition

Rank Sector Weight
1 Technology 17.22%
2 Healthcare 16.95%
3 Financials 13.07%
4 Industrials 9.55%
5 Communication Services 8.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RPV icon
276
Invesco S&P 500 Pure Value ETF
RPV
$1.67B
$77.2K 0.03%
925
K
277
DELISTED
Kellanova
K
$75.7K 0.02%
+1,312
New +$77.4K
AOS icon
278
A.O. Smith
AOS
$8.23B
$75.2K 0.02%
920
GLD icon
279
SPDR Gold Trust
GLD
$131B
$75K 0.02%
349
AZN icon
280
AstraZeneca
AZN
$240B
$70.8K 0.02%
454
AZZ icon
281
AZZ Inc
AZZ
$4.39B
$69.7K 0.02%
902
NMT icon
282
Nuveen Massachusetts Quality Municipal Income Fund
NMT
$129M
$69K 0.02%
6,207
ON icon
283
ON Semiconductor
ON
$32.4B
$68.5K 0.02%
1,000
REGN icon
284
Regeneron Pharmaceuticals
REGN
$78.7B
$68.3K 0.02%
65
+10
+18% +$9.69K
AMT icon
285
American Tower
AMT
$80.7B
$68.2K 0.02%
351
-35
-9% -$6.54K
TMC icon
286
TMC The Metals Company
TMC
$1.58B
$67.5K 0.02%
50,000
+25,000
+100% +$38.3K
VUG icon
287
Vanguard Morningstar Growth ETF
VUG
$224B
$65.1K 0.02%
1,044
LIT icon
288
Global X Lithium & Battery Tech ETF
LIT
$1.5B
$65K 0.02%
1,676
DXC icon
289
DXC Technology
DXC
$1.84B
$64.9K 0.02%
3,400
-6,500
-66% -$122K
ICLN icon
290
iShares Global Clean Energy ETF
ICLN
$2.36B
$64.5K 0.02%
4,843
+423
+10% +$5.92K
PM icon
291
Philip Morris
PM
$295B
$64.3K 0.02%
635
GEV icon
292
GE Vernova
GEV
$267B
$63.6K 0.02%
+371
New +$58.8K
YUMC icon
293
Yum China
YUMC
$16.6B
$63.2K 0.02%
2,050
-400
-16% -$14.6K
IWS icon
294
iShares Russell Mid-Cap Value ETF
IWS
$15.7B
$62.3K 0.02%
516
CAG icon
295
Conagra Brands
CAG
$7.03B
$62.2K 0.02%
+2,188
New +$65.8K
BP icon
296
BP
BP
$114B
$62.1K 0.02%
1,720
+19
+1% +$712
LW icon
297
Lamb Weston
LW
$7.2B
$61.4K 0.02%
+730
New +$62.3K
LH icon
298
Labcorp
LH
$24.9B
$61.1K 0.02%
300
ARKK icon
299
ARK Innovation ETF
ARKK
$5.81B
$55.9K 0.02%
1,272
+302
+31% +$13.5K
NRK icon
300
Nuveen New York AMT-Free Quality Municipal Income Fund
NRK
$899M
$55.8K 0.02%
5,036

Similar funds

Brown, Lisle/Cummings's Q2 2024 Portfolio in Review

As of Q2 2024, Brown, Lisle/Cummings held 624 positions worth $307M, up 4.2% from $294M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Brown, Lisle/Cummings deployed $10M of net new capital in Q2 2024, opening 65 new positions and adding to 120 existing holdings. Its largest new stake was Waste Management: 1,750 shares worth $373K.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was W.P. Carey, an estimated $312K trimmed.

  • Brown, Lisle/Cummings's largest Q2 2024 buy was Waste Management: 1,750 shares worth $373K.
  • Brown, Lisle/Cummings added most to Microsoft in Q2 2024, an estimated $1.18M increase.
  • Brown, Lisle/Cummings's biggest Q2 2024 reduction was W.P. Carey, cutting an estimated $312K.
  • Brown, Lisle/Cummings fully exited Qiagen in Q2 2024, selling an estimated $83.4K.
  • Brown, Lisle/Cummings's ten largest holdings make up 29% of its $307M portfolio in Q2 2024.
  • Brown, Lisle/Cummings opened 65 new positions and closed 11 in Q2 2024.
  • Brown, Lisle/Cummings's portfolio value rose 4.2% quarter-over-quarter to $307M.

Based on Brown, Lisle/Cummings's 13F filing for Q2 2024, filed 17 Jul 2024.